Bioequivalence Study in Healthy Subjects
8
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations
Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations
Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations
Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans
Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions
Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations